Literature DB >> 31101226

LncRNA MALAT1 aggravates inflammation response through regulating PTGS2 by targeting miR-26b in myocardial ischemia-reperfusion injury.

Zhihua Ruan1, Shuang Wang2, Wenqian Yu1, Fan Deng3.   

Abstract

Entities:  

Keywords:  Inflammation; LncRNA MALAT1; MiR-26b; Myocardial ischemia/reperfusion injury; PTGS2

Mesh：

Substances：

Year:  2019        PMID： 31101226     DOI： 10.1016/j.ijcard.2019.04.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  11 in total

1.  Integrative analyses of immune-related biomarkers and associated mechanisms in coronary heart disease.

Authors:  Lianbo Zhang; Guibin Li; Bo Liang; Xiaoli Su; Haolin Xie; Hongxia Sun; Ge Wu
Journal:  BMC Med Genomics       Date:  2022-10-20       Impact factor: 3.622

2.  Piperine protects against myocardial ischemia/reperfusion injury by activating the PI3K/AKT signaling pathway.

Authors:  Yun-Peng Li; Zhen Chen; Yu-Hua Cai
Journal:  Exp Ther Med       Date:  2021-02-19       Impact factor: 2.447

Review 3.  Long Noncoding RNA/Circular RNA-miRNA-mRNA Axes in Ischemia-Reperfusion Injury.

Authors:  Chengwu Gong; Xueliang Zhou; Songqing Lai; Lijun Wang; Jichun Liu
Journal:  Biomed Res Int       Date:  2020-11-25       Impact factor: 3.411

4.  lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p.

Authors:  Ye Wang; Bin Zhou; Liping Yan; Jianhui Wu; Zhijie Xing; Shaochun Zhang; Fusheng Xiang
Journal:  Exp Ther Med       Date:  2021-04-18       Impact factor: 2.447

5.  Study on the Multitarget Mechanism and Active Compounds of Essential Oil from Artemisia argyi Treating Pressure Injuries Based on Network Pharmacology.

Authors:  Shu-Ting Lu; Lu-Lu Tang; Ling-Han Zhou; Ying-Tao Lai; Lan-Xing Liu; Yifan Duan
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.650

6.  Exploring the Mechanism of Hawthorn Leaves Against Coronary Heart Disease Using Network Pharmacology and Molecular Docking.

Authors:  Jie Ding; Jun Wu; Haoran Wei; Sui Li; Man Huang; Yan Wang; Qin Fang
Journal:  Front Cardiovasc Med       Date:  2022-06-16

7.  Downregulation of DEC1 by RNA interference attenuates ischemia/reperfusion-induced myocardial inflammation by inhibiting the TLR4/NF-κB signaling pathway.

Authors:  Weipan Xu; Kai Zhang; Yi Zhang; Shanxue Ma; Daoqun Jin
Journal:  Exp Ther Med       Date:  2020-04-30       Impact factor: 2.447

8.  Nobiletin alleviates ischemia/reperfusion injury in the kidney by activating PI3K/AKT pathway.

Authors:  Bo Liu; Quanhong Deng; Lei Zhang; Wen Zhu
Journal:  Mol Med Rep       Date:  2020-10-01       Impact factor: 2.952

Review 9.  Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury.

Authors:  Miłosz Majka; Marcin Kleibert; Małgorzata Wojciechowska
Journal:  Cells       Date:  2021-11-27       Impact factor: 6.600

10.  LncRNA MALAT1-deficiency restrains lipopolysaccharide (LPS)-induced pyroptotic cell death and inflammation in HK-2 cells by releasing microRNA-135b-5p.

Authors:  Jie Huang; Chen Xu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.